Image 1 of 1
Image 1 of 1
Image 1 of 1
Image 1 of 1
Adipotide, also listed as FTTP, is a peptidomimetic investigated for targeting blood vessels that supply white adipose tissue. Preclinical studies in obese monkeys reported reductions in body fat and improvements in insulin resistance. Its vascular targeting mechanism differs from appetite-focused incretin compounds, and animal findings do not define a predictable human response.
Key research interests
• White adipose tissue vasculature
• Body fat changes in animal models
• Insulin resistance in preclinical studies
Not for human or veterinary use
Adipotide, also listed as FTTP, is a peptidomimetic investigated for targeting blood vessels that supply white adipose tissue. Preclinical studies in obese monkeys reported reductions in body fat and improvements in insulin resistance. Its vascular targeting mechanism differs from appetite-focused incretin compounds, and animal findings do not define a predictable human response.
Key research interests
• White adipose tissue vasculature
• Body fat changes in animal models
• Insulin resistance in preclinical studies
Not for human or veterinary use